NATA presents at the 3rd Dutch Antisense Therapeutics Symposium
NATA recently took part in the 3rd Dutch Antisense Therapeutics Symposium, where our Research Assistant Inês Fial presented our latest research on "Characterising antibodies targeting antisense oligonucleotide (ASO) modifications for quantification of intracellular trafficking and in vivo biodistribution."
Inês discussed the use of Rockland Immunochemicals' ModDetect mouse monoclonal antibodies, specifically targeting the P-S bond, to effectively visualise NATs within cells and tissues. These antibodies are instrumental in visualising co-localisation with cellular markers, observing alternative backbone modifications and are applicable in both in vitro and in vivo studies.
As NATA continues to collaborate with leading experts, Inês’ contributions demonstrate the passion and dedication of our team. We are proud of our team's commitment and hard work in advancing our research capabilities. Together, we aim to push forward through high-quality science, interdisciplinary collaborations, and a focus on improving lives through innovative research.
To learn more, you can download the poster here.